Medtronic Settles Patent Spat Over Stents
Wall Cardiovascular Technologies LLC has settled its claims against Medtronic Inc. in a suit over cardiovascular stent patents, leaving Johnson & Johnson and its subsidiary Cordis Corp. as the only remaining...To view the full article, register now.
Already a subscriber? Click here to view full article